Tyler Perrin-Bellelo, MD, FACP, D-ABOM Internal Medicine | Obesity Medicine #ADA2026 #ObesityMedicine #Retatrutide #GLP1 #ObesityResearch | Tyler Perrin Bellelo, M.D.
This level of leadership reflects deep mastery, not just familiarity, with these treatments
9 SGLT2 Inhibitors in Type 1 Diabetes (T1D) SGLT2 inhibitors may also be of beneft in T1D, in addition to insulin, although they have not yet been approved for this indication
Clinically Supported Weight Loss & Appetite Regulation
While these are population-level numbers, the principle applies to individuals as well: routine injection visits for non-deficient patients add up in copays, travel time, and appointment scheduling without delivering additional benefit